baber/WOPTO huggingface dataset:
Patent NZ-505055-A (NZ)
Title: Foldable tote box with locking insert tabs longer and narrower than the holding tabs
Inventor: CHU LAWRENCE H Y
IPC: B65D85/50
Filed: 1999-09-08
Abstract: A foldable tote box is formed by a one-piece corrugated board,   especially   corrugated   plastic,   including    a rectangular bottom panel (2), a pair of sidewall panels  (1) and  a  pair of end wall panels (7, 8). Each sidewall  panel (1)  has a pair of filler beam panels (4-6) forming a hollow support  beam. Each end wall panel includes a  wall  section (8)  and  a  flap  section (7) on which a  pair  of  locking insert  tabs (66) are formed to be engaged with  a  pair  of holding  tabs  (77)  on the filler beam panels  (4-6).  Each holding  tab is said to be formed in one corner  panel.  The locking  insert tabs and holding tabs are formed by  cutting lines.  The locking insert tabs (66) are longer and narrower than  the holding tab (77) allowing insertion of the locking insert  tabs (66) as the holding tabs (77) are pressed  away from  the  filler beam panel (4-6), and, upon  release,  the holding tabs (66) can hold and lock the locking insert  tabs (66).
Patent NZ-506412-A (NZ)
Title: Retracting needle syringe with automatic withdrawal  of needle cannula into syringe barrel after use
Inventor: CIPOLETTI ROBERT
IPC: A61M5/32
Filed: 2000-01-04
Abstract: Retracting  needle syringe (20) includes  barrel  (22) having  chamber (24), open proximal end (25) and open distal end  (26). The plunger has an elongated cavity (34)  in  its distal   end  and  a  sealing  cover  element  (35).  Needle assembly (40) includes needle cannula (41) having inner  hub with  distal  end connected so that the lumen  is  in  fluid communication  with the chamber. A flange on the  inner  hub is  connected  to  an  outer hub and a spring  is  contained between the hubs. A release element is movably connected  to the  flange and has a sharp proximal end projecting into the chamber.  Distal  motion  of the plunger  causes  the  sharp proximal  end  to  cut  through the cover  element  and  the release  element  to  dissociate an  outer  portion  of  the flange  from  an  inner portion of the flange  allowing  the spring  to  expand  and  move the needle  cannula  into  the cavity.
Patent NZ-509594-A (NZ)
Title: High gain fluid control valve assembly with valve stem having rigid and resilient enlarged portions sealing against respective resilient upstream and rigid downstream portions of housing
Inventor: CAMPAU DANIEL N
IPC: F15C3/00
Filed: 2001-01-26
Abstract: Apparatus for controlling flow of a fluid includes: i) a body portion (12) having one or more inlets and first and second opposing outlets; the first outlet (20) having a relatively rigid valve seat (28) defining a first valve outlet port and the second outlet (22) having a flexible valve seat (42) defining a second valve outlet port; ii) a valve support assembly (26) including a stem portion (38) and configured for movement relative to the first and second outlets; the valve support assembly including a flexible valve member (40) mounted to the stem portion; the flexible valve member having sufficient size to block flow through the first valve outlet port when in contact with the rigid valve seat; iii) the stem positioned relative to the body portion so that the flexible valve member is positioned inside the body portion upstream of the first valve outlet port; iv) an enlarged portion (30) of the stem being located downstream of the second valve outlet port and being larger than the second valve outlet port to block flow when in contact with the flexible valve seat; such that when the valve support assembly is in a first open position, both the flexible valve member and the enlarged portion are spaced from the first valve outlet port and the second valve outlet port, respectively, allowing fluid introduced into the body to exit the body through the first and second outlet ports and when the valve support assembly is in a second closed position, both the flexible valve member and the enlarged portion are in sealing contact with the flexible valve seat and the rigid seat, respectively, shutting off the flow of fluid through the valve body. The apparatus defined above can be used to fill batteries.
Patent NZ-512538-A (NZ)
Title: Nonaqueous sizing composition for application to glass reinforcing fibers comprising a film former, a coupling agent and a polyamide powder
Inventor: MILLER DAVID G
IPC: C03C25/10
Filed: 1999-12-13
Abstract: A  nonaqueous  sizing composition for  application  to glass reinforcing fibers comprising: i)   One or more film formers ii)  One or more coupling agents iii) One or more polyamide powders. Also described are glass fibers having at least a portion of their  surfaces  covered  with  the  dried  residue  of  the nonaqueous sizing composition described above. Also  described  is a process for producing  a  glass  fiber having  improved processability and shock loading comprising the steps of: i)   Forming glass fiber strand ii)   Coating  the  glass fiber strand with  the  nonaqueous sizing composition described above. Also  described  is  a  nonaqueous  sizing  composition  for application  to  glass fibers for reinforcing  polypropylene comprising: i)    One  or  more  film  formers that  are  miscible  with polypropylene ii)  One or more coupling agents iii)  One  or more powders having a molecular weight  of  at least 12 000.
Patent NZ-513644-A (NZ)
Title: Method of treating of preventing non-viral microbial infection
Inventor: WALKER EDWARD B
IPC: A01N65/00
Filed: 2001-08-20
Abstract: Described are proanthocyanidin monomers, dimers, polymers, flavonoid, and flavonoid derivatives and related compounds used for their ability to interfere with bacterial adherence to a surface. Crystalline proanthocyanadin dimer and plant extracts enriched with such compounds are also disclosed.
Patent NZ-513719-A (NZ)
Title: Bogie and pivot for multifold panel assemblies
Inventor: HANCOCK MICHAEL JOHN
IPC: E06B3/48
Filed: 2000-07-04
Abstract: A pivot providing unit comprising a bogie for supporting or suspending a panel of a multifold door or window, where the panels are hinged together about a vertical axis and lie in the plane of the top and bottom tracks when closed.  Pivot providing unit also comprises a pivot axis-defining member dependent from the bogie including means to mount the pivot axis to the panel.  The pivot axis-defining member is mounted in advance (C) of the rotational axes of the wheels (4)of the bogie.
Patent NZ-517396-A (NZ)
Title: Pharmaceutical compositions containing lipase inhibitors and fatty acid esters of polyols
Inventor: DE SMIDT PASSCHIER CHRISTIAAN
IPC: A61K47/14
Filed: 2000-09-11
Abstract: A pharmaceutical composition comprises at least inhibitor of lipase and at least one fatty acid ester of polyols. The fatty acid ester has a melting point above the body temperature and the polyols are chosen from glycerol, sugars, sugar derivatives and mixtures thereof. The compositions can be used in the treatment and prevention of obesity.
Patent NZ-529420-A (NZ)
Title: Delivery of antihistamines through an inhalation route
Inventor: RABINOWITZ JOSHUA D
IPC: F24V30/00
Filed: 2002-05-21
Abstract: Disclosed is a composition for delivery of an antihistamine comprising: a condensation aerosol which is formed by volatilising an antihistamine under conditions effective to produce a heated vapour of the antihistamine and condensing the heated vapour of the antihistamine to form condensation aerosol particles; wherein said condensation aerosol particles are characterised by less than 5% antihistamine degradation products; and wherein the aerosol has an MMAD of less than 5 microns.
Patent NZ-532020-A (NZ)
Title: Coin dispenser and control method for the coin dispenser
Inventor: ITAKO EIJI
IPC: G07D9/00
Filed: 2003-07-02
Abstract: A coin dispenser which includes a plurality of coin tubes for storing inserted coins by coin type and coin delivery means for selectively delivering coins from bottom ends of the coin tubes is disclosed, which comprises: a coin counter means for counting coins accumulated in each of the coin tubes; detection means for detecting a coin tube having a prescribed number or less of accumulated coins, into which another coin is newly accumulated, according to count outputs of the coin counter means, and recognizing the coin tube as an idle struck coin tube; and a delivery control means which, if an idle struck coin tube is detected by the detection means, executes, at the time of the delivery of coins by the coin delivery means, an idle striking operation, wherein a delivery operation is performed such that coins are prohibited from being delivered from the idle struck coin tube.
Patent NZ-538401-A (NZ)
Title: (1H-benzoimidazol-2-yl)-(piperazinyl)-methanone derivatives and related compounds as histamine H4-receptor antagonists for the treatment of inflammatory and allergic disorders
Inventor: CARRUTHERS NICHOLAS I
IPC: C07D471/04
Filed: 2003-09-04
Abstract: Certain thienopyrrolyl and furanopyrrolyl compounds described as (1H-benzoimidazol-2-yl)-(piperazinyl)-methanone derivatives of formula (I) are disclosed as useful to treat or prevent disorders and conditions mediated by the histamine H4 receptor, including allergic rhinitis.
Patent NZ-541879-A (NZ)
Title: Bovine vaccination or immunization using a prime-boost regimen against BRSV, BHV-1, BVDV, BPI-3 and DMRIE
Inventor: AUDONNET JEAN-CHRISTOPHE FRANCIS
IPC: A61P11/00
Filed: 2003-02-19
Abstract: Disclosed are bovine prime-boost vaccination methods and kits directed against a bovine pathogen selected from a bovine respiratory syncytal virus, bovine parainfluenza virus 5 type-3, bovine herpes virus type-1, and bovine viral diarrhea. The methods comprise administering to a bovine a priming vaccine composition which comprises a DNA molecule encoding and expressing an immunogen from the pathogen, and DMRIE. Subsequently a second but different boosting vaccine is administered, that contains or expresses at least the same immunogen of the same pathogen. Further disclosed are the use of viral vectors and plasmids for the aforementioned method.
Patent NZ-542010-A (NZ)
Title: Closure for a container
Inventor: MISHRA PRABHAT RANJAN
IPC: B65D55/02
Filed: 2004-03-18
Abstract: A closure (1) for a container (2) which comprises a cap, the cap being adapted in use to sealably engage the opening of a container, the cap having a frangible portion (3) adapted in use to be connected through a tearing strip (4) to the container to prevent disengagement of the cap from the opening of the container and the frangible portion being removable from the cap by pulling on the tearing strip, thereby in use, allowing the cap to be disengaged from sealable engagement with the opening of the container.
Patent NZ-542267-A (NZ)
Title: Diagnosis and treatment of multiple sulfatase deficiency and other sulfatase deficiencies
Inventor: VON FIGURA KURT
IPC: A61K38/00
Filed: 2004-02-10
Abstract: Provided is an isolated sulfatase-producing cell wherein the ratio of active sulfatase to total sulfatase produced by the cell is increased, wherein the cell expresses: (i) a sulfatase, wherein the sulfatase is an activated form of an endogenous sulfatase or an exogenous sulfatase, and wherein expression of the sulfatase is increased as compared to expression in the same cell type without the activated form of the sulfatase; and (ii) a Formylglycine Generating Enzyme, wherein the Formylglycine Generating Enzyme is an exogenous eukaryotic Formylglycine Generating Enzyme, and wherein expression of the Formylglycine Generating Enzyme is increased as compared to expression in the same cell type without the activated form of the Formylglycine Generating Enzyme, wherein the ratio of active sulfatase to total sulfatase produced by the cell is increased by at least 5% over the ratio of active sulfatase to total sulfatase produced by the cell in the absence of the Formylglycine Generating Enzyme. Further provided are such cells containing specific genes and sequences of FGE and sulfatase when produced by such cells.
Patent NZ-544858-A (NZ)
Title: Salinosporamides and methods for use thereof
Inventor: FENICAL WILLIAM H
IPC: C12P17/18
Filed: 2004-06-18
Abstract: Disclosed is a compound of formula (I), wherein the substituents are as defined in the specification. The compounds are anti-neoplastic agents useful in the treatment of cell proliferative disorders.
Patent NZ-548771-A (NZ)
Title: Phosphonates, monophosphonamidates, bisphosphonamidates for the treatment of viral diseases
Inventor: CHENG XIAQIN
IPC: A61K31/675
Filed: 2004-12-29
Abstract: Disclosed are 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine derivatives as represented by the general formula IA or a pharmaceutically acceptable salt thereof, wherein: Y1A and Y1B are independently NH(Rx); where RX is as defined herein. Also disclosed is the use of a compound as defined above in the preparation of a medicament for the treatment of tumors, and wherein the medicament may further comprise an effective amount of at least one antiviral agent, and a pharmaceutically acceptable carrier.
Patent NZ-551203-A (NZ)
Title: A method of monitoring a predetermined type of molecule conveyed through a gaseous medium
Inventor: WENZHI WU
IPC: G01N27/12
Filed: 2005-04-21
Abstract: A system for monitoring a predetermined type of molecule conveyed through a gaseous medium comprises at least one electronic detector for detecting the predetermined type of molecule. The or each detector is arranged for measuring the molecules of the predetermined type to detect a quantity of the molecules and to produce electronic data associated with the quantity of the molecules. The system also has a processor for analysing the electronic data to provide information that can be used to control a source of the predetermined type of molecule. The processor is arranged to predict probable future data and generates an alarm signal if it is predicted that the molecules of the predetermined type will have a level that is above a threshold level. A method of analysing data from a detector for detecting a predetermined type of molecule conveyed through a gaseous medium comprises receiving sequences of first data from the detector, training an artificial neural network using the sequences of the first data so that the trained artificial neural network can be used to predict probable future data that is sequential to received second data, receiving the second data from the detector, processing the second data using the trained artificial neural network to predict the probable future data, and generating an alarm signal if it is predicted that the molecules of the predetermined type will have a level that will be above a threshold value.
Patent NZ-553673-A (NZ)
Title: Pharmaceutical composition in the form of a gastric-resident tablet containing an active principle
Inventor: ALAUX GERARD
IPC: A61K9/00
Filed: 2005-08-17
Abstract: Disclosed is a pharmaceutical composition in the form of a gastric retention matrix tablet comprising an active ingredient, comprising one or more phases, wherein at least one of the phases contains at least, as excipients: a) povidone and/or polyvinyl acetate in proportions ranging from 30 to 80% by weight of the phase, b) crospovidone in proportions ranging from 5 to 25% by weight of the phase, and c) carbomer in proportions ranging from 5 to 40% by weight of the phase. The composition is designed to rapidly swell up on contact with gastric juices so that has a longer residence in the stomach and avoids the premature release of the active ingredient. An example of a suitable active ingredient is Alfuzosin hydrochloride.
Patent NZ-556335-A (NZ)
Title: Cinnamate salts of a beta-2 adrenergic agonist
Inventor: VERNON LOIS ELIZABETH
Filed: 2006-01-09
Abstract: Disclosed are cinnamate salts of a compound of formula (I), wherein the salts are selected from a cinnamate, 4-methoxycinnamate, di-(4- phenylcinnamate) and 4-methyl cinnamate salt. Also disclosed is a method for preparing these cinnamate salts in crystalline form, wherein the method comprises contacting in solution 5-[(R)-2-(2-{4-[4-(2-amino-2-methyl-propoxy)-phenylamino]-phenyl}-ethylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one with an acid selected from cinnamic acid, 4-methoxycinnamic acid, di-(4-phenylcinammic acid) and 4-methylcinnamic acid.
Patent NZ-567978-A (NZ)
Title: Influenza vaccine with reduced amount of oil-in-water emulsion as adjuvant
Inventor: CONTORNI MARIO
IPC: A61K39/39
Filed: 2006-11-06
Abstract: Disclosed is a process of producing an adjuvanted influenza vaccine composition, said process comprising: (a) preparing at least one influenza virus antigen comprising haemagglutinin, wherein said at least one influenza virus antigen is from at least one influenza virus strain obtained by reverse genetics techniques; and (b) mixing substantially equal volumes of (i) a submicron oil-in-water emulsion adjuvant comprising a squalene and (ii) an aqueous preparation comprising the at least one influenza virus antigen, wherein the vaccine composition comprises less than 30ug hemagglutinin per influenza virus strain per ml.
Patent NZ-568318-A (NZ)
Title: A hair clip with two combs joined by biasing member
Inventor: GLADWIN THEA
IPC: A45D8/00
Filed: 2006-11-02
Abstract: A hair clip which includes opposing first (12) and second (14) combs, each of which has a body (18) with an upper side and an underside (20) (with upper side not being visible in the drawings), a plurality of spaced apart teeth (21) which extend from the body (18) and a plurality of attachment means (22a, 22b, 22c) on the body (18) , each of which has an individual recess formation on the underside (20) and at least two spaced apart apertures which extend in the recess formation and between the underside and the upper side, and a biasing member which is attached to the first and second combs (14) and which is engaged with the plurality of attachment means (22a, 22b, 22c) .
Patent NZ-568606-A (NZ)
Title: Ultrasonic non-destructive testing
Inventor: CAWLEY PETER
IPC: B06B3/00
Filed: 2006-09-14
Abstract: An elongate strip of ultrasound transmissive material is coupled at a proximal end to an object for ultrasonic non-destructive testing. The strip has a transverse cross-section with a width and thickness giving an aspect ratio greater than unity and is matched to an attached ultrasonic transducer such that excitation induces a non-dispersive ultrasonic signal to propagate along the strip to the proximal end and to enter the object under test.
Patent NZ-569709-A (NZ)
Title: A method of operating a multi-mode flashlight
Inventor: OSIECKI SCOTT W
IPC: F21V3/00
Filed: 2007-11-20
Abstract: A lighting device, particularly a flashlight (200), that has an infrared light source and one or more further light sources, and methods for operating the light device, are disclosed. The device has two or more modes of operation selectable by operation of two or more switches. The infrared light source has a dedicated operating switch (204), with a latch (248) able to selectively enable or inhibit operation of the infrared light switch. (62) Divided Out of 563575
Patent NZ-574188-A (NZ)
Title: Humanized antibody against amyloid beta
Inventor: PFEIFER ANDREA
IPC: C07K16/18
Filed: 2007-07-13
Abstract: An antibody that recognises and binds to beta-amyloid and exhibits both and aggregation inhibition property as well as a disaggregation property. The antibody comprises a heavy chain variable region having the amino acid sequence of SEQ ID NO: 15 or 16 and a light chain variable region having the amino acid sequence of SEQ ID NO: 12 or 13. The antibody can be used to treat amyloidosis in Alzheimer's disease.
Patent NZ-576494-A (NZ)
Title: Once-a-day oxycodone formulations
Inventor: OSHLACK BENJAMIN
IPC: A61K9/48
Filed: 2002-05-02
Abstract: Disclosed is a sustained-release oral dosage form for once-a-day administration comprising: a pharmaceutically acceptable sustained-release matrix including (a) an analgesically effective amount of oxycodone or a pharmaceutically acceptable salt thereof in the range from 1 mg to 640 mg, and (b) a sustained release material comprising a mixture of (i) a C12-C36 aliphatic alcohol, (ii) a C8-C50 fatty acid, and (iii) a hydrophobic polymer in an effective amount to render the dosage form suitable for once-a-day oral administration as part of the matrix, the dosage form providing an analgesic effect for at least about 24 hours and a mean C24/Cmax oxycodone ratio of 0.7 to 0.99 after once-a-day steady state oral administration to human patients.
Patent NZ-589311-A (NZ)
Title: Angiogenin-enriched milk fractions prepared by methods involving heating the milk to over 70 degrees celsius for at least one minute
Inventor: MCDONAGH MATTHEW
IPC: C07K14/515
Filed: 2009-05-14
Abstract: Disclosed are methods for enriching a milk extract for angiogenin, such methods involving separation by size, charge or immunoaffinity. The invention also provides the angiogenin enriched extract produced by the methods and provides them in pharmaceutical and neutraceutical compositions and foods for treating a variety of diseases or disorders that can be treated by angiogenin.
Patent NZ-592085-A (NZ)
Title: Improvements to manhole assemblies
Inventor: FULLER BRIAN
IPC: E02D29/14
Filed: 2012-10-19
Abstract: 592085 Disclosed is a bracket (29) to facilitate connecting a sewer to a manhole. The bracket (29) includes a joint between a first pipe (36) and a second pipe (37), with the first pipe (36) having a first end (41) within the joint and a second end outside of the joint. The second pipe (37) has a first end (45) within the joint and a second end outside of the joint so as to facilitate connecting the second pipe (37) to a bowl within the manhole. The joint is configured to enable the first (36) and second pipes (37) to be rotated about their respective longitudinal axis (X, Y) so as to change the angle between the first pipe (36) and the second pipe (37).
Patent NZ-592696-A (NZ)
Title: Use of extracts from rabbit skin inflamed by vaccinia virus for the manufacture of a medicament for the treatment of acute cerebrovascular disease
Inventor: LAU MANSANG
IPC: A61K35/36
Filed: 2009-10-23
Abstract: 592696 Disclosed is the use of an extract from rabbit skin inflamed by vaccinia virus in the manufacture of a medicament for treatment of an acute cerebrovascular disease in a mammal, wherein said disease is selected from cerebral embolism, transient cerebral ischemia attack, cerebral thrombosis, cerebral arteriosclerosis, cerebral arteritis, steal syndrome of cerebral artery, cranial venous sinus and venous thrombus.
Patent NZ-593850-A (NZ)
Title: Pan for refrigeration of food with coil and different thicknesses of insulation at sides and bottom for even cooling
Inventor: WALKER DARREL J
IPC: F25D31/00
Filed: 2005-06-20
Abstract: A temperature control system is disclosed for maintaining a food product at an acceptable temperature. The control system comprises a pan (20) having a thermally conductive vertical wall and a thermally conductive bottom side. A first member surrounds the pan and a channel is disposed between the first member and the pan. The channel contains a fluid contacting the thermally conductive vertical wall (30) and the thermally conductive bottom side of the pan. A refrigeration coil is connected to a top portion of the thermally conductive vertical wall for cooling the pan (20) and a second member surrounds a bottom portion of the thermally conductive vertical wall.